Insider Brief: The pharmaceutical industry has a major opportunity that it may as of yet be largely unaware of. While traditional drug development remains mired in decade-long timelines, billion-dollar budgets, and staggering failure rates exceeding 90%, an opportunity is quietly taking shape 400 kilometers above Earth. Microgravity environments, a core part of space biotechnology, are … Continue reading Space Biotech as a Strategic Advantage: Why Early Movers Stand to Win Billions